Dr. Agarwal's Health Care Limited (BOM:544350)
India flag India · Delayed Price · Currency is INR
471.40
+3.65 (0.78%)
At close: Jun 22, 2026

Dr. Agarwal's Health Care Statistics

Total Valuation

BOM:544350 has a market cap or net worth of INR 149.68 billion. The enterprise value is 158.47 billion.

Market Cap149.68B
Enterprise Value 158.47B

Important Dates

The next estimated earnings date is Monday, August 3, 2026.

Earnings Date Aug 3, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 316.96M
Shares Outstanding n/a
Shares Change (YoY) +6.27%
Shares Change (QoQ) +0.61%
Owned by Insiders (%) 28.95%
Owned by Institutions (%) 11.43%
Float 60.39M

Valuation Ratios

The trailing PE ratio is 112.38 and the forward PE ratio is 80.61.

PE Ratio 112.38
Forward PE 80.61
PS Ratio 7.20
PB Ratio 7.06
P/TBV Ratio 17.15
P/FCF Ratio 210.70
P/OCF Ratio 28.84
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.82, with an EV/FCF ratio of 223.07.

EV / Earnings 118.98
EV / Sales 7.62
EV / EBITDA 27.82
EV / EBIT 54.03
EV / FCF 223.07

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.50.

Current Ratio 1.24
Quick Ratio 0.96
Debt / Equity 0.50
Debt / EBITDA 1.87
Debt / FCF 15.01
Interest Coverage 3.24

Financial Efficiency

Return on equity (ROE) is 8.31% and return on invested capital (ROIC) is 7.20%.

Return on Equity (ROE) 8.31%
Return on Assets (ROA) 4.82%
Return on Invested Capital (ROIC) 7.20%
Return on Capital Employed (ROCE) 8.43%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.55
Inventory Turnover 13.26

Taxes

In the past 12 months, BOM:544350 has paid 805.00 million in taxes.

Income Tax 805.00M
Effective Tax Rate 32.38%

Stock Price Statistics

The stock price has increased by +16.07% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +16.07%
50-Day Moving Average 454.83
200-Day Moving Average 470.44
Relative Strength Index (RSI) 61.49
Average Volume (20 Days) 4,886

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BOM:544350 had revenue of INR 20.80 billion and earned 1.33 billion in profits. Earnings per share was 4.18.

Revenue20.80B
Gross Profit 9.24B
Operating Income 2.93B
Pretax Income 2.49B
Net Income 1.33B
EBITDA 5.70B
EBIT 2.93B
Earnings Per Share (EPS) 4.18
Full Income Statement

Balance Sheet

The company has 2.82 billion in cash and 10.66 billion in debt, with a net cash position of -7.85 billion.

Cash & Cash Equivalents 2.82B
Total Debt 10.66B
Net Cash -7.85B
Net Cash Per Share n/a
Equity (Book Value) 21.20B
Book Value Per Share 63.76
Working Capital 1.11B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.19 billion and capital expenditures -4.48 billion, giving a free cash flow of 710.40 million.

Operating Cash Flow 5.19B
Capital Expenditures -4.48B
Depreciation & Amortization 2.76B
Net Borrowing -2.23B
Free Cash Flow 710.40M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 44.44%, with operating and profit margins of 14.10% and 6.40%.

Gross Margin 44.44%
Operating Margin 14.10%
Pretax Margin 11.95%
Profit Margin 6.40%
EBITDA Margin 27.38%
EBIT Margin 14.10%
FCF Margin 3.42%

Dividends & Yields

BOM:544350 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 0.82%
Buyback Yield -6.27%
Shareholder Yield -6.27%
Earnings Yield 0.89%
FCF Yield 0.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Analyst Forecast

The average price target for BOM:544350 is 545.00, which is 15.61% higher than the current price. The consensus rating is "Buy".

Price Target 545.00
Price Target Difference 15.61%
Analyst Consensus Buy
Analyst Count 5
Revenue Growth Forecast (3Y) 20.45%
EPS Growth Forecast (3Y) 40.44%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 7